GSK plc GSK announced that it has entered into a definitive agreement with Massachusetts-based privately held biopharmaceutical company, Affinivax, Inc., wherein it will acquire the latter for an ...

GlaxoSmithKline on Wednesday lifted its long-term outlook following the smash-hit launch of its new RSV vaccine last year. The shot, called Arexvy, booked £1.2 billion ($1.5 billion) in sales after ...

(Reuters) -GSK on Tuesday agreed to buy U.S. biotech Affinivax for up to $3.3 billion, its second major deal in two months, giving the British pharmaceutical giant access to the company's roster of ...

GSK plc GSK announced that it has entered into a definitive agreement to acquire California-based biotech RAPT Therapeutics RAPT for an estimated aggregate equity value of $2.2 billion. The impending ...

LONDON (Reuters) -GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit growth, lifting the British company's shares by nearly 7% to ...

GSK on Tuesday upped its 2024 profit guidance, as surging sales of its HIV drugs and recently launched shingles vaccine saw it beat analyst expectations in the first quarter of the year. The FTSE-100 ...

GSK posted higher profit as sales for its specialty treatments including HIV, cancer and asthma beat expectations, offsetting lower vaccine sales on weak demand in the U.S. GSK plans to bring five new ...